Navigation Links
EmSense Announces Release of Revolutionary EmBand 24(TM)
Date:3/22/2010

SAN FRANCISCO, March 22 /PRNewswire/ -- EmSense Corporation, the company that created the first scalable electroencephalography (EEG) brainwave measurement technology, today announced the addition of the EmBand 24™ to the EmBand™ family of neuromarketing measurement devices.

(Photo: http://www.newscom.com/cgi-bin/prnh/20100322/AQ74210)

Using its Made for Purpose™ design, EmSense has employed several new proprietary technologies in the release of the new EmBand 24, including Sensor Fusion Processors™, Contact Clusters™ and Through the Hair EEG™.  The headset is designed specifically for market research and overcomes many limitations of using medical EEG for market research. 

"Now marketers can have more extensive, robust measurements without trading off consumer comfort, quantitative samples or ease of use," says Keith Winter, EmSense CEO.

EmSense proprietary sensors provide more targeted measurement with greater precision than medical sensors.  The Contact Cluster technology enables the ability to take individual anatomical differences into account and give maximum spatial resolution in targeted regions. New Through the Hair EEG sensors allow non-obtrusive measurement without the need for unpleasant, messy gels that require respondent clean-up. 

Using 24 EEG sensors, each measuring at 20,000 times per second, the headset collects 480,000 measurements per second.  In addition, the EmBand 24 provides an unparalleled signal-to-noise ratio in real-world, in-context conditions.  In keeping with the company's non-invasive design philosophy, the EmBand 24 headset does not require caps, gels or wires and calibrates in only one minute. 

"With the global availability of the EmBand 24," according to Chief Analytics Officer Elissa Moses, "the ability to objectively understand consumer engagement and emotional response will ultimately accelerate the success rate for ad campaigns, package restages and new product introductions."

The EmBand 24 affords clients increased measurement in the key decision center area of the frontal lobes, as well as added measurements such as visual attention from sensing additional areas of the brain.  The new EmBand 24 will primarily be utilized for in-context studies such as in-store shopper research and product innovation, while the current EmBand will continue to be used for advertising, concepts, media content, package testing, online marketing and web-site usability. 

About EmSense

EmSense is a leading-edge neuroscience company that applies advances in EEG and other neurometrics to provide clients with deep and reliable understanding of consumers' emotional and cognitive engagement with marketing stimuli. The company's quantitative metrics deliver breakthrough insights that facilitate the creation and optimization of advertising, concepts, packaging, media content, online marketing, web-site usability and both the live in-store and virtual store shopping experiences.  EmSense works directly with marketers and also partners with a variety of leading established market research firms including Dynamic Logic, Fifth Dimension, GfK North America, IRI, Millward Brown, Perception Research Services, Red Dot Square and TNS. EmSense provides expertise and advancements in emotion tracking, cognitive neuroscience, analytics, and market research through their proprietary EmBand and now EmBand 24, the first ever wireless, scalable, non-gel, non-invasive EEG neuroscience technology. The company is also the global leader in combining neurometrics with stationary and mobile eye tracking. EmSense Corporation is headquartered in San Francisco. To learn more about EmSense technology applications and neuroscience market research solutions, visit www.emsense.com.

SOURCE EmSense

Back to top

RELATED LINKS
http://www.emsense.com

'/>"/>

SOURCE EmSense
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... , Jan. 20, 2017  Today, ... Symposia Conference, "PI3K Pathways in Immunology, Growth ... (NASDAQ: INFI ) presented ... development candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). ... to help overcome resistance to checkpoint inhibition ...
(Date:1/21/2017)... , Jan. 20, 2017  Faruqi & Faruqi, LLP, ... Inc. ("KemPharm" or the "Company") (NASDAQ: KMPH ) ... Company and certain officers and directors and underwriters of the ... seek the role of lead plaintiff. The lawsuit ... District Court for Johnson County on ...
(Date:1/20/2017)... , Jan 20, 2017 Research and ... Aids Market (by Devices, Implant Types, OTC Amplifiers, Diagnostic Instruments), ... to their offering. ... Global Hearing Aids Market Sales Volume, Company Analysis ... fast-evolving, high-growth hearing aid industry. The growing prevalence ...
Breaking Medicine Technology:
(Date:1/22/2017)... ... January 22, 2017 , ... Zifam Pinnacle, an Australian company dedicated to providing ... big-name retail buyers at the January ECRM Trade Show in Hilton Head, SC. , ... safety standards in all of its creations to help create a more traditional and ...
(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... ... January 21, 2017 , ... Salveo for life, a company ... its product to the United States as part of its presence to expand its ... Alcovit aims to reduce the productions of nasty toxins as a result of drinking ...
(Date:1/21/2017)... ... ... Seamild, the largest manufacturer of oats in China, is now aiming at global ... is recognized globally as one of the healthiest cereals, XieQingkui, the founder of Seamild, ... move to sow the seed of good karma. Buddhism spirit featuring benevolence and sacrifice ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting ... family, friends, and community. “Coming Home 2017” will be held on Friday ...
Breaking Medicine News(10 mins):